Biotech

All Articles

Takeda takes $140M reduction on stopped working epilepsy medicine, proclaims FDA run

.Our company currently know that Takeda is actually hoping to discover a pathway to the FDA for epil...

VBI Injections apply for insolvency, seeks possession sale

.Immunology biotech VBI Injections is drifting precariously close to the defining moment, along with...

Celldex anti-cKIT antibody reduce colonies in another period 2 study

.It's hard to muscular tissue in on a space as competitive as immunology, however Celldex Therapeuti...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapeutics and a preclinic...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medicine did certainly not aid patients achieve remission in a ...

Cognition's stage 2 radiate records tarnish Alzheimer's prospect

.Knowledge Rehabs' stage 2 luster trial has actually taken a number of the luster off the Alzheimer'...

BMS axes bispecific months after filing to run phase 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapeutics' $ 5.8 billion purchase to Bristol ...

Asarina to shut after attempts to companion Tourette's medication fail

.After reaching out to more than 200 companies to companion a Tourette disorder therapy that reveale...

Novartis pens $150M beforehand bispecifics manage Dren Bio

.Novartis has actually had some bad luck along with bispecific antitoxins before, yet judging by the...